Published in Medical Letter on the CDC and FDA, July 19th, 2009
"These criteria are disseminated to all VHA facilities. To (a) assess the concordance with VHA guidelines for use of 4 antiretrovirals (atazanavir, darunavir, entuvirtide, and tipranavir), and (b) to describe prescribing of these agents before and after implementation of the guideline criteria," wrote P.S. Belperio and colleagues.
The researchers concluded: "In this retrospective cohort study, we evaluated all...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA